Nonpegylated liposomal doxorubicin: reduction in cardiotoxicity, although still severe alopecia

Anticancer Drugs. 2015 Jul;26(6):687. doi: 10.1097/CAD.0000000000000239.

Authors

Corina van den Hurk¹, Wim Breed, Wouter Dercksen

Affiliation

¹ aResearch Department, Netherlands Comprehensive Cancer Organisation bDepartment of Oncology, Máxima Medical Centre, Eindhoven cGive Hair a Change Foundation, Waalre, The Netherlands.

PMID: 26010159
DOI: 10.1097/CAD.0000000000000239

No abstract available

Publication types

Comment

MeSH terms

Antibiotics, Antineoplastic / pharmacology*
Cardiotoxicity / prevention & control*
Doxorubicin / adverse effects*
Drug Delivery Systems / methods*
Humans
Liposomes / therapeutic use*

Substances

Antibiotics, Antineoplastic
Liposomes
Doxorubicin